Phibro Animal Health Corp (NASDAQ:PAHC) insider Jack Bendheim sold 30,000 shares of the firm’s stock in a transaction dated Thursday, August 23rd. The stock was sold at an average price of $50.04, for a total value of $1,501,200.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Jack Bendheim also recently made the following trade(s):

  • On Wednesday, September 12th, Jack Bendheim sold 520 shares of Phibro Animal Health stock. The stock was sold at an average price of $45.04, for a total value of $23,420.80.
  • On Thursday, September 6th, Jack Bendheim sold 20,000 shares of Phibro Animal Health stock. The stock was sold at an average price of $47.14, for a total value of $942,800.00.
  • On Tuesday, August 21st, Jack Bendheim sold 10,000 shares of Phibro Animal Health stock. The stock was sold at an average price of $50.35, for a total value of $503,500.00.
  • On Monday, August 13th, Jack Bendheim sold 10,000 shares of Phibro Animal Health stock. The stock was sold at an average price of $50.03, for a total value of $500,300.00.
  • On Wednesday, August 15th, Jack Bendheim sold 30,000 shares of Phibro Animal Health stock. The shares were sold at an average price of $49.75, for a total value of $1,492,500.00.
  • On Monday, August 6th, Jack Bendheim sold 10,000 shares of Phibro Animal Health stock. The shares were sold at an average price of $50.66, for a total value of $506,600.00.
  • On Wednesday, August 8th, Jack Bendheim sold 30,000 shares of Phibro Animal Health stock. The shares were sold at an average price of $50.20, for a total value of $1,506,000.00.
  • On Wednesday, July 25th, Jack Bendheim sold 4,000 shares of Phibro Animal Health stock. The shares were sold at an average price of $47.37, for a total value of $189,480.00.
  • On Friday, July 27th, Jack Bendheim sold 12,000 shares of Phibro Animal Health stock. The shares were sold at an average price of $47.35, for a total value of $568,200.00.
  • On Thursday, July 19th, Jack Bendheim sold 17,470 shares of Phibro Animal Health stock. The shares were sold at an average price of $47.92, for a total value of $837,162.40.

Shares of Phibro Animal Health stock traded down $0.35 on Friday, reaching $43.75. The company had a trading volume of 196,948 shares, compared to its average volume of 162,580. The stock has a market cap of $1.81 billion, a price-to-earnings ratio of 25.75, a price-to-earnings-growth ratio of 2.59 and a beta of 0.89. The company has a debt-to-equity ratio of 1.62, a quick ratio of 1.66 and a current ratio of 2.90. Phibro Animal Health Corp has a 1 year low of $32.05 and a 1 year high of $54.62.

Phibro Animal Health (NASDAQ:PAHC) last announced its earnings results on Monday, August 27th. The company reported $0.46 EPS for the quarter, topping the Zacks’ consensus estimate of $0.42 by $0.04. The firm had revenue of $211.80 million during the quarter, compared to analysts’ expectations of $209.27 million. Phibro Animal Health had a return on equity of 39.81% and a net margin of 7.90%. The company’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.39 EPS. sell-side analysts predict that Phibro Animal Health Corp will post 1.8 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 26th. Stockholders of record on Wednesday, September 5th will be issued a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a dividend yield of 0.91%. The ex-dividend date of this dividend is Tuesday, September 4th. Phibro Animal Health’s dividend payout ratio (DPR) is 22.99%.

Several hedge funds have recently modified their holdings of the stock. Bank of New York Mellon Corp lifted its stake in shares of Phibro Animal Health by 3.2% during the 2nd quarter. Bank of New York Mellon Corp now owns 349,574 shares of the company’s stock worth $16,097,000 after acquiring an additional 10,895 shares during the last quarter. California Public Employees Retirement System lifted its stake in shares of Phibro Animal Health by 7.6% during the 2nd quarter. California Public Employees Retirement System now owns 38,619 shares of the company’s stock worth $1,778,000 after acquiring an additional 2,723 shares during the last quarter. Macquarie Group Ltd. lifted its stake in shares of Phibro Animal Health by 16.3% during the 2nd quarter. Macquarie Group Ltd. now owns 9,998 shares of the company’s stock worth $460,000 after acquiring an additional 1,400 shares during the last quarter. Cubist Systematic Strategies LLC bought a new stake in shares of Phibro Animal Health during the 2nd quarter worth approximately $255,000. Finally, Renaissance Technologies LLC lifted its stake in shares of Phibro Animal Health by 18.2% during the 2nd quarter. Renaissance Technologies LLC now owns 634,500 shares of the company’s stock worth $29,219,000 after acquiring an additional 97,700 shares during the last quarter. 50.45% of the stock is owned by hedge funds and other institutional investors.

PAHC has been the subject of several research analyst reports. Zacks Investment Research upgraded Phibro Animal Health from a “sell” rating to a “buy” rating and set a $53.00 price target for the company in a report on Thursday, August 30th. BidaskClub upgraded Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Wednesday, August 8th. Morgan Stanley lifted their target price on Phibro Animal Health from $36.00 to $46.00 and gave the stock an “underweight” rating in a report on Wednesday, August 29th. Finally, Barclays lifted their target price on Phibro Animal Health from $31.00 to $33.00 and gave the stock an “underweight” rating in a report on Thursday, July 5th. Two analysts have rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $43.20.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture.

Further Reading: Discover Your Risk Tolerance

Insider Buying and Selling by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.